SCHEMBL6750562

SCHEMBL6750562

CS(=O)(=O)CCn1[c]cc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.37
USP2 O75604 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA12 O43570 1/20 0.33
BRD4 O60885 1/20 0.33
BRPF1 P55201 1/20 0.33
CA9 Q16790 1/20 0.33
KAT2B Q92831 1/20 0.33
BRD9 Q9H8M2 1/20 0.33
PER2 O15055 1/20 0.32
CRY1 Q16526 1/20 0.32
CRY2 Q49AN0 1/20 0.32
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
PTGER4 P35408 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C19 P33261 2/20 0.31
MEN1 O00255 1/20 0.30
ESR1 P03372 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1200553 0.78 POLB (0.39) HTTUSP2SMN1; SMN2CA12BRD4
SCHEMBL4142894 0.75 TLR8 (0.41) USP2SMN1; SMN2CDK4CCND1MEN1
SCHEMBL5254830 0.74 CDK4 (0.35) CDK4CCND1MEN1KMT2AALDH1A1
SCHEMBL5134510 0.73 TLR8 (0.43) HTTCDK4CCND1CYP1A2CYP2C19
SCHEMBL6753797 0.73 HTR2C (0.56) HTTCDK4CCND1CYP1A2ALDH1A1
SCHEMBL5497336 0.73 CYP1A2 (0.35) HTTUSP2SMN1; SMN2CA12BRD4
SCHEMBL11719132 0.72 TLR8 (0.44) HTTSMN1; SMN2CDK4CCND1CYP1A2
SCHEMBL6754260 0.72 SMN1; SMN2 (0.33) HTTSMN1; SMN2CDK4CCND1CYP1A2
SCHEMBL16235846 0.72 HTR6 (0.31)
SCHEMBL6753315 0.71 CDK4 (0.35) CDK4CCND1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US claimed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US claimed
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US disclosed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077646-A1 Indole nitriles TPH1, IDO1, NAT1 HTT 641/4885USP2 1927/4885SMN1; SMN2 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.